Pediatrics, Nephrology

Organization

School of Medicine > Clinical Science Departments > Pediatrics > Pediatrics, Nephrology

Overview

People

Embed Organization Data

Embed Organization Data

Recent Scholarship

scholar cap and tassel

book

Featured Publications

APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Journal Article Kidney Int · November 2025 Full text Link to item Cite

Growth after pediatric and neonatal acute kidney injury: a meta-analysis.

Journal Article Pediatr Nephrol · November 2025 Full text Link to item Cite

Association of Dietary Sodium and Potassium With Blood Pressure and Proteinuria in Africans With Kidney Disease

Journal Article Kidney International Reports · October 1, 2025 Full text Cite

Search More

Featured Grants

Phase 2b Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants with APOL1-Mediated Ki

Clinical Trial · Awarded by AstraZeneca AB · 2025 - 2029

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers

Research · Awarded by Wake Forest University Health Sciences · 2018 - 2028

Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT)

Research · Awarded by Northwell Health Care · 2024 - 2028

Phase 2b, Open-label Study to Evaluate the Efficacy and Safety of Inaxaplin in Subjects With Proteinuric APOL1-mediated Kidney Disease With or Without Comorbidities that May Independently Contribute t

Clinical Trial · Awarded by Vertex Pharmaceuticals Inc. · 2025 - 2027

Emerald2 RLY5016-208p Vifor- A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 6 Years of Age with Hyperkalaemia

Clinical Trial · Awarded by CSL Behring LLC · 2024 - 2027

Search More